Pump Science roadmap update: Mouse experiments for URO and RIF will be conducted in January next year
Pump Science has released an updated roadmap, which includes: announcing a partnership on December 24th, preparing for mouse experiments and protocol development; initiating URO and RIF mouse experiments on January 25th, 2025; collaborating with VitaDAO to launch new compounds on February 25th; launching supplement pre-orders and market platform on March 25th; conducting decentralized human trials and launching decentralized compound releases on April 25th; expanding related experiments on May 25th.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBP sees September Fed hold as US inflation cools further
U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%
On Monday, storage chip concept stocks generally rose, with SanDisk (SNDK.US) up by 6%.
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds
On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.
Nvidia invests $1.5 billion in SB Energy to support Ohio AI data center campus
Crypto prices
More
